CLINICAL_TRIALS
trial_result
· 2016-05-16
Clinical Trial Update: sCD163 in ALS Patients
Summary
A completed clinical trial at University of Aarhus investigated soluble CD163 in patients with amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Aarhus | Conditions: Amyotrophic Lateral Sclerosis | Status: COMPLETED